by John Thomaszewicz | Blog
Silgan Closures has selected enterade as co-winner of its 2019 annual new product competition. A medical food product that Entrinsic Health CMO Joe Del Regno says has been called life-changing by those consumers using it to combat the GI side effects of chemotherapy...
by John Thomaszewicz | Blog
Background: Gastroenteropancreatic neuroendocrine tumor (GEPNET) incidence has risen 6-fold over past 3 decades. North American Neuroendocrine Tumor Society estimates that over 100,000 GEPNET patients are currently living in the United States. One of the common...
by John Thomaszewicz | Blog
The National Cancer Institute estimates that by 2025, an estimated 2.1 million people in the United States will be diagnosed with cancer every year. This is a 31-percent increase from 2012, which is due in an aging population and increase in cancer screening. The...
by John Thomaszewicz | Blog
January is Cervical Cancer Awareness Month, and enterade is proud to help raise awareness for a cancer that impacts more than 13,000 women annually. Nearly all cases of cervical cancer are caused by the human papillomavirus (HPV), a common virus that is passed from...
by John Thomaszewicz | Blog
Each New Year provides us with a clean slate, an opportunity to rethink how we approach each day and how we can tackle goals that have seemed out of reach in the past. While obstacles exist for everyone, cancer patients also have added struggles ranging from...